Equities

Croda International Plc

CRDA:LSE

Croda International Plc

Basic MaterialsChemicals
  • Price (GBX)4,610.00
  • Today's Change-15.00 / -0.32%
  • Shares traded690.30k
  • 1 Year change-33.95%
  • Beta0.7602
Data delayed at least 20 minutes, as of Apr 30 2024 17:08 BST.
More ▼

Profile data is unavailable for this security.

About the company

Croda International PLC is a life sciences and consumer care company. Its segments include Consumer Care, Life Sciences and Industrial Specialties. The Consumer Care segment is focused on high-value niches in the markets of skin care, hair care, solar protection, fabric and surface care, and fragrances. The Consumer Care comprises four businesses: beauty care, beauty actives, home care and fragrances and flavors. Its Life Sciences segment is engaged in providing quality health care solutions, protecting crops and enhancing seeds. The Company is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein and nucleic acid delivery platforms. It is engaged in offering ingredients that improve the performance and delivery of crop formulations. It offers seed coating systems to improve germination, stimulate healthy development of seeds and crop yield. It is also focused on biotechnology-derived active ingredients for beauty care and pharmaceuticals.

  • Revenue in GBP (TTM)1.69bn
  • Net income in GBP171.00m
  • Incorporated1925
  • Employees5.85k
  • Location
    Croda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 14 0586 0551Fax+44 14 0586 1767
  • Websitehttps://www.croda.com/en-gb
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Siegfried Holding AG1.11bn97.57m3.48bn3.93k3.48bn3.93k
Krka d.d. Novo Mesto1.54bn268.07m3.53bn11.67k3.53bn11.67k
Richter Gedeon Vegyeszeti Gyar Nyrt1.76bn346.67m3.79bn12.17k3.79bn12.17k
Laboratorios Farmaceuticos ROVI SA708.29m145.44m3.81bn2.11k3.81bn2.11k
Hikma Pharmaceuticals Plc2.29bn151.26m4.26bn8.97k4.26bn8.97k
Orion Oyj1.04bn185.12m4.39bn3.70k4.39bn3.70k
Grifols SA5.63bn50.65m4.40bn23.74k4.40bn23.74k
Zealand Pharma A/S39.24m-80.56m4.43bn253.004.43bn253.00
DiaSorin SpA980.41m136.49m4.60bn3.23k4.60bn3.23k
BACHEM HOLDING AG502.71m97.40m5.30bn2.01k5.30bn2.01k
Croda International Plc1.69bn171.00m6.46bn5.85k6.46bn5.85k
Swedish Orphan Biovitrum AB (publ)1.68bn155.54m7.29bn1.75k7.29bn1.75k
Qiagen NV1.57bn271.88m7.46bn5.97k7.46bn5.97k
Ipsen SA2.82bn526.92m8.05bn5.33k8.05bn5.33k
Recordati Industria Chmc Frmctc SpA1.78bn332.33m8.82bn4.46k8.82bn4.46k
Data as of Apr 30 2024. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX

Institutional shareholders

34.83%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 08 Feb 20249.80m7.02%
Massachusetts Financial Services Co.as of 22 Jun 20237.01m5.02%
Mawer Investment Management Ltd.as of 31 Dec 20216.44m4.61%
The Vanguard Group, Inc.as of 01 Apr 20245.54m3.97%
RBC Global Asset Management (UK) Ltd.as of 31 Dec 20225.01m3.59%
BlackRock Fund Advisorsas of 01 Apr 20243.50m2.51%
MFS International (UK) Ltd.as of 01 Apr 20243.49m2.50%
Impax Asset Management Ltd.as of 01 Apr 20242.89m2.07%
BlackRock Advisors (UK) Ltd.as of 01 Apr 20242.51m1.80%
Legal & General Investment Management Ltd.as of 01 Apr 20242.44m1.75%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.